Filing Flows › Koru Medical Systems (KRMD) › Q1 2026 › vs Q1 2025
Koru Medical Systems (KRMD) Q1 2026 vs Q1 2025 (year over year)
Koru Medical Systems's revenue rose $2.1M (+22%) from $9.6M in Q1 2025 to $11.8M in Q1 2026.
Koru Medical Systems, Q1 2026: revenue $11.8M (+22% year over year), operating margin -7.4%, net loss $807K, operating cash flow $15K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $11.8M | $9.6M | $2.1M | +22% |
| Other income, net | $58K | $79K | −$21K | -27% |
| Net loss | $807K | $1.2M | −$359K | -31% |
| Costs & expenses | $12.6M | $10.9M | $1.7M | +16% |
| Operating costs | $12.6M | $10.9M | $1.7M | +16% |
| Cost of revenue | $4.5M | $3.6M | $944K | +26% |
| Research & development | $1.3M | $1.1M | $202K | +18% |
| SG&A | $6.6M | $6.0M | $623K | +10% |
| Other operating costs | $198K | $217K | −$20K | -9% |
| Operating cash sources | $879K | $915K | −$36K | -4% |
| Depreciation & amortization | $198K | $217K | −$20K | -9% |
| Share-based compensation | $682K | $698K | −$16K | -2% |
| Net loss absorbed | $807K | $1.2M | −$359K | -31% |
| Working capital & other | $57K | −$14K | $71K | — |
| Operating cash flow | $15K | −$237K | $252K | — |
| Capital expenditures | $46K | $443K | −$397K | -90% |
| Negative free cash flow (OCF − capex) | $32K | $681K | −$649K | -95% |
Questions
How much did Koru Medical Systems's revenue grow year over year in Q1 2026?
Koru Medical Systems's revenue rose $2.1M (+22%) from $9.6M in Q1 2025 to $11.8M in Q1 2026.